Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 111 results found. Search for [ Novavax ]

Results 20 to 40 of 111
BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


BusinessToday.In
October 2, 2020
In a research paper published in the journal PAIN, the scientists raised the possibility that pain, as an early symptom of COVID-19, may be reduced by the coronavirus spike protein as it silences the \"body's pain signaling pathways\"


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


PB Jayakumar
September 29, 2020
The vaccines will have a ceiling price of US$3 per dose, thanks to investments made by partners such as the Coalition for Epidemic Preparedness Innovations (CEPI) and the Bill & Melinda Gates Foundation


BusinessToday.In
New Delhi, September 23, 2020
Adar Poonawalla is the CEO of his family-owned company Serum Institute of India, which is the world's largest manufacturer of vaccines by volume. Poonawalla, who is in the spotlight in the global vaccine race for coronavirus, has promised to manufacture 400 million doses per month after the approval of the coronavirus vaccine. He has become the biggest hope for the global community during the pandemic. Serum Institute is currently conducting phase 3 clinical trials for the Oxford University-AstraZeneca vaccine. Here is all you need to know about the man himself and how he might prove to be our best bet during the pandemic. Watch the video for more.Also Read: Serum Institute to conduct clinical trials for Novavax COVID-19 vaccine


BusinessToday.In
September 17, 2020
Addressing the Rajya Sabha over the coronavirus situation in the country, Dr. Harsh Vardhan said that India is also making efforts like other nations, adding that \"three vaccine candidates are in different phases\" of clinical trials


BusinessToday.In
September 17, 2020
Adar Poonawalla-helmed Serum Institute had partnered with Novavax in August for the production of its coronavirus vaccine. The US drug developer plans to manufacture 2 billion doses annually


Reuters
September 16, 2020
China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech


BusinessToday.In
September 16, 2020
Besides, the drug regulating body of the country has told the Serum Institute to take extra care during screening, provide additional information in informed consent, and closely monitor participants for any adverse events during follow-up of the study


Reuters
September 16, 2020
In August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India


BusinessToday.In
September 15, 2020
The head of the world's largest vaccine manufacturer said that the world will need 15 billion doses of the COVID-19 shot if it is a two-dose vaccine


BusinessToday.In
September 13, 2020
Pfizer says trial is event-based and there are many variables that will ultimately impact read-out timing; adds if trials are successful, these companies would submit vaccines for approval as early as October


BusinessToday.In
September 11, 2020
Another leading candidate for coronavirus vaccine is Moderna. The company said that it is talking to multiple countries for the rollout of the COVID-19 vaccine.


BusinessToday.In
September 9, 2020
AstraZeneca said in a statement that its COVID-19 vaccine candidate's trials have been halted, not stopped, as it is going to conduct a review of safety data by an independent committee


BusinessToday.In
September 8, 2020
Adar Poonawalla's Serum Institute of India had signed a deal with British-Swedish pharma company AstraZeneca to manufacture the potential vaccine developed by the Jenner Institute of Oxford University


BusinessToday.In
September 6, 2020
Russia's medical watchdog Roszdravnadzor will soon assess vaccine for quality check and could get approval by September 13, following which government will authorise vaccine for civilian use


BusinessToday.In
September 3, 2020
The 2020 Fortune 40 under 40 list highlights 40 influential people each in five categories of technology, healthcare, finance, media and entertainment, and government and politics from across the world


BusinessToday.In
September 1, 2020
COVID-19 vaccine: The University of Oxford and AstraZeneca PLC has developed the first vaccine candidate to start the final round of testing of the coronavirus vaccine


BusinessToday.In
September 1, 2020
Coronavirus vaccine update: AstraZeneca is one of the leading contenders in the race to develop coronavirus vaccine


PAGES 2 OF 6  12345